PAPPA2
protein-codingpappalysin 2, the group of Pappalysins|Sushi domain containing
Gene summary
This gene encodes a member of the pappalysin family of metzincin metalloproteinases. The encoded protein cleaves insulin-like growth factor-binding protein 5 and is thought to be a local regulator of insulin-like growth factor (IGF) bioavailability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2010]
- PLAC3
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~382.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0859182
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0859182
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0859182
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Endocrine; Musculoskeletal; Neurologic
Intervention: Endocrine
Rationale: The condition can involve decreased growth, and response to prepubertal administration of growth hormone has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PAPPA2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_020318.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 18 | 2 | 26 | ||
| missense | 1 | 1 | 250 | 31 | 1 | 284 |
| nonsense | 5 | 1 | 6 | |||
| start loss | 0 | |||||
| frameshift | 3 | 2 | 5 | |||
| splice donor/acceptor (+/-2bp) | 1 | 2 | 3 | |||
| Total | 9 | 5 | 258 | 49 | 3 | 324 |
Highest pathogenic variant AF is 0.000017347495
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_064714.2 | 22 | MANE Select | |
| Ensembl | ENSP00000356634.3 | 22 | MANE Select | |
| RefSeq | NP_068755.2 | 4 | Standard | |
| Ensembl | ENSP00000356633.3 | 4 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| pappa2 | Danio rerio | Structure: cranial neural crest cell Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Metabolism of proteins
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
Biological Process
- regulation of cell growth
- proteolysis
- response to salt stress
- cellular protein metabolic process
- bone morphogenesis
Molecular Function
- metalloendopeptidase activity
- metallopeptidase activity
- zinc ion binding
Cellular Component
- extracellular region
- cytosol
- apical plasma membrane
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000367662
- Coding exons
- 22
- Length
- 382429
- Individuals with no LoFs
- 124771
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 45
- Defined
- 124816
- p
- 0.000180
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.09 | 921 | 1.02e+3 | 0.904 | 0.0000583 | 11715 |
| Missense (PolyPhen) | 280 | 381.34 | 0.73426 | 4470 | ||
| Synonymous | 0.707 | 377 | 395 | 0.955 | 0.0000230 | 3543 |
| Loss of Function | 5.27 | 27 | 76.8 | 0.351 | 0.00000363 | 924 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00013 | rare |
| Latino/Admixed American | 0.00020 | 0.00020 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.00028 | 0.00028 | rare |
| European (Non-Finnish) | 0.00020 | 0.00019 | rare |
| South Asian | 0.000099 | 0.000098 | rare |
| Other | 0.00017 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Metalloproteinase which specifically cleaves insulin- like growth factor binding protein (IGFBP)-5 at the '163-Ser-|- Lys-164' bond. Shows limited proteolysis toward IGFBP-3. {ECO:0000269|PubMed:11264294}.;
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- LoFtool
- 0.594
- RVIS EVS
- -1.49
- RVIS percentile EVS
- 3.62
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.486
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |